TRPV2 |
DNA |
upregulated |
prognosis |
recurrence |
tissue |
34936030 |
h-caldesmon |
protein |
upregulated |
diagnosis |
|
tissue |
34556086 |
RRBP1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30684972 |
RRBP1 |
protein |
upregulated |
treatment |
potential target |
tissue |
30684972 |
SNF5 |
protein |
upregulated |
treatment |
therapies target/Knockdown of SNF5 inhibits the expression of p21 |
tissue |
30683081 |
STC2 |
protein |
upregulated |
prognosis |
unfavorable/recurrence |
tissue |
30661222 |
SMOC-2 |
protein |
upregulated |
treatment |
therapeutic target, enhanced resistance toward chemotherapy |
tissue |
30594556 |
L1CAM |
protein |
upregulated |
diagnosis |
aggressive tumor behavior and recurrence riskrisk |
tissue |
30591489 |
miR-142 |
RNA |
|
treatment |
therapeutic target |
tissue |
30585737 |
miR-142 |
RNA |
downgulated |
prognosis |
unfavorable |
tissue |
30585737 |
MMR status |
DNA |
dMMR |
prognosis |
unfavorable,recurrence |
tissue |
30561762 |
L1CAM |
protein |
upregulated |
diagnosis |
pre-operative predictor of lymph node involvement |
tissue |
30557309 |
p16 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
34473724 |
LncRNA FER1L4 |
RNA |
downgulated |
prognosis |
unfavorable |
tissue |
30556848 |
PD-L1 |
protein |
upregulated |
prognosis |
unfavorable( associated with clinicopathologic variables of advanced disease) |
tissue |
30539847 |
HIF-1α |
protein |
upregulated |
prognosis |
unfavorable( associated with clinicopathologic variables of advanced disease) |
tissue |
30539847 |
Patched-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30521558 |
Jag1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30521558 |
MMR |
protein |
MMR deficient |
prognosis |
unfavorable |
tissue |
30521558 |
endoglin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30479213 |
CK19 |
DNA |
upregulated |
diagnosis |
LN metastasis |
tissue |
30428472 |
MMP20 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30377136 |
Autotaxin |
DNA |
upregulated |
treatment |
therapeutic target |
tissue |
30374843 |
CTNNB1 |
DNA |
CTNNB1 exon 3 mutation |
prognosis |
unfavorable |
tissue |
34420090 |
ALDH1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30372483 |
CD44 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
30372483 |
ALDH1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
30372483 |
CD44 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
30372483 |
lymphocyte infiltration (LI) |
cell |
downgulated |
prognosis |
unfavorable |
tissue |
30282081 |
PD-1 |
protein |
upregulated |
treatment |
potential target for
immunotherapy |
tissue |
30134343 |
PD-L1 |
protein |
upregulated |
treatment |
potential target for immunotherapy |
tissue |
30134343 |
PD-L2 |
protein |
upregulated |
treatment |
potential target for immunotherapy |
tissue |
30134343 |
MACC1 |
protein |
upregulated |
diagnosis |
|
tissue |
29984790 |
c-Myc |
protein |
upregulated |
diagnosis |
|
tissue |
29984790 |
CTNNB1 |
DNA |
CTNNB1 exon 3 mutation |
diagnosis |
|
tissue |
34420090 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable, high risk of recurrence |
tissue |
29980240 |
miR-34a |
RNA |
downgulated |
prognosis |
unfavorable, high risk of recurrence |
tissue |
29980240 |
GLP-1R |
protein |
upregulated |
prognosis |
favorable |
tissue |
29907137 |
GLP-1R |
protein |
upregulated |
treatment |
novel potential treatment |
tissue |
29907137 |
GLP-1R |
protein |
upregulated |
prognosis |
favorable |
tissue |
29907137 |
PR |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
AR |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
ER-alpha |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
PR |
protein |
upregulated |
prognosis |
favorable |
tissue |
29869299 |
AR |
protein |
upregulated |
prognosis |
favorable |
tissue |
29869299 |
CTNNB1 |
DNA |
CTNNB1 exon 3 mutation |
prognosis |
unfavorable |
tissue |
34420090 |
ER-alpha |
protein |
upregulated |
prognosis |
favorable |
tissue |
29869299 |
ABHD11-AS1 |
RNA |
upregulated |
treatment |
Target |
tissue |
29799152 |
PIR2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
29724995 |
RNF144B |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
29724995 |
DFF40 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
29653556 |
DFF40 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
29653556 |
BCL2 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
29653556 |
BCL2 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
29653556 |
PD-L1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
29572029 |
PD-L1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
29572029 |
CTNNB1 |
DNA |
CTNNB1 exon 3 mutation |
diagnosis |
|
tissue |
34420090 |
CD8 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
29572029 |
TRIM44 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
29526558 |
UCHL1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
29489474 |
UCHL1 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
29489474 |
mPRβ |
DNA |
upregulated |
prognosis |
favorable |
tissue |
29353001 |
mPRβ |
protein |
upregulated |
prognosis |
favorable |
tissue |
29353001 |
mPRγ |
DNA |
upregulated |
prognosis |
favorable |
tissue |
29353001 |
mPRγ |
protein |
upregulated |
prognosis |
favorable |
tissue |
29353001 |
CaSR |
protein |
upregulated |
prognosis |
predictor for endometrial cancer progression |
tissue |
29348629 |
CIP2A |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
29274810 |
PR |
protein |
upregulated |
diagnosis |
|
tissue |
34418427 |
HER2 |
protein |
upregulated |
treatment |
benefit of anti-HER2 treatments |
tissue |
29169184 |
Asparaginase-like protein 1 |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
29096882 |
Asparaginase-like protein 1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
29096882 |
cyclin D1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
28965628 |
NTSR1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
28836043 |
CD133 |
protein |
upregulated |
prognosis |
favorable |
tissue |
28794448 |
L1CAM |
protein |
upregulated |
prognosis |
predicts lymph node metastases |
tissue |
28751757 |
IFITM1 |
protein |
upregulated |
diagnosis |
|
tissue |
28700435 |
GalNAc-T6 |
protein |
upregulated |
diagnosis |
better histological grade |
tissue |
28668893 |
NAV2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
28643014 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
34418427 |
NAV2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
28643014 |
CCND2 |
protein |
upregulated |
prognosis |
favorable |
tissue |
28643014 |
CCND2 |
protein |
upregulated |
prognosis |
favorable |
tissue |
28643014 |
SerpinE2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
28453461 |
SerpinE2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
28453461 |
EZH2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
28418882 |
androgen receptor (AR) |
protein |
upregulated |
prognosis |
favorable |
tissue |
28277313 |
SHP-1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
28187032 |
SHP-1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
28187032 |
miR-944 |
RNA |
upregulated |
prognosis |
unfavorable |
tissue |
28178620 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
34418427 |
miR-944 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
28178620 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
28155970 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
28155970 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
28155970 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
28155970 |
NF-YAs |
protein |
upregulated |
diagnosis |
identify G1 ECs patients with risk of recurrence. |
tissue |
27974701 |
lamin A |
protein |
upregulated |
diagnosis |
identify G1 ECs patients with risk of recurrence. |
tissue |
27974701 |
HSD17B1 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
27923582 |
HSD17B1 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
27923582 |
HSD17B2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
27923582 |
L1CAM |
protein |
upregulated |
diagnosis |
|
tissue |
34418427 |
S100P |
protein |
upregulated |
diagnosis |
quamous cell and adenosquamous carcinoma subtypes of endometrial cancer. |
tissue |
27918216 |
S100P |
protein |
upregulated |
treatment |
drug target,quamous cell and adenosquamous carcinoma subtypes of endometrial cancer |
tissue |
27918216 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
27902476 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
27902476 |
ALCAM |
protein |
upregulated |
prognosis |
recurrent |
tissue |
27873306 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27648714 |
HIF-1α |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27634881 |
UCA1 |
RNA |
upregulated |
prognosis |
unfavorable |
tissue |
27540975 |
GGT |
protein |
upregulated |
prognosis |
favorable |
tissue |
27512000 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27488577 |
TRPV2 |
DNA |
upregulated |
diagnosis |
|
tissue |
34936030 |
PR |
protein |
upregulated |
diagnosis |
|
tissue |
34418427 |
Fzd2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27373314 |
SIX1 |
protein |
upregulated |
diagnosis |
|
tissue |
27259717 |
PAX1 |
protein |
upregulated |
prognosis |
favorable |
tissue |
27226215 |
PAX1 |
protein |
upregulated |
diagnosis |
|
tissue |
27226215 |
ERRα |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27153547 |
HDACs 1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27127168 |
HDACs 4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27127168 |
HDACs 6 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27127168 |
HDACs 7 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27127168 |
HDACs 8 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
27127168 |
LCOR |
protein |
upregulated |
prognosis |
favorable |
tissue |
34410950 |
HDACs 1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 4 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 6 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 7 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 8 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
IFITM1 |
protein |
upregulated |
diagnosis |
absence of invasion |
tissue |
27124937 |
USP14 |
protein |
upregulated |
prognosis |
recurrence |
tissue |
27121063 |
clusterin |
protein |
upregulated |
diagnosis |
|
tissue |
27079858 |
CD103 |
protein |
upregulated |
prognosis |
favorable |
tissue |
27038842 |
SLUG |
protein |
upregulated |
prognosis |
unfavorable(recurrence) |
tissue |
27003026 |
LCOR |
protein |
upregulated |
diagnosis |
|
tissue |
34410950 |
SLUG |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27003026 |
CD169 |
protein |
upregulated |
treatment |
monitoring anti-tumor immunity |
tissue |
26991548 |
MIF |
protein |
upregulated |
diagnosis |
|
tissue |
26985869 |
c-erbB-2 |
protein |
upregulated |
diagnosis |
|
tissue |
26985869 |
MIF |
DNA |
upregulated |
diagnosis |
|
tissue |
26985869 |
c‑erbB‑2 |
DNA |
upregulated |
diagnosis |
|
tissue |
26985869 |
S18-2 |
protein |
upregulated |
prognosis |
favorable |
tissue |
26959119 |
E2F1 |
protein |
upregulated |
prognosis |
favorable |
tissue |
26959119 |
Estrogen receptor-alpha |
protein |
upregulated |
diagnosis |
higher grade and advanced stage |
tissue |
26957478 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26891628 |
rs1137101 |
DNA |
A>G |
prognosis |
protective factor in the development of endometrial cancer |
tissue |
34399708 |
ZNF154 CpG |
DNA |
upregulated |
diagnosis |
identifying solid tumor DNA |
tissue |
26857064 |
NUCB2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26842712 |
Nup88 |
protein |
upregulated |
diagnosis |
pre-malignant lesions and early-stage |
tissue |
26839161 |
Nup88 |
protein |
upregulated |
diagnosis |
pre-malignant lesions and early-stage |
tissue |
26839161 |
POLE |
DNA |
upregulated |
prognosis |
favorable |
tissue |
26763250 |
infiltrating macrophages |
cell |
upregulated |
prognosis |
|
tissue |
26744532 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26743472 |
GAL-3 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26708131 |
CRIP-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26708131 |
NRP-1 |
protein |
upregulated |
prognosis |
predicator of metastatic |
tissue |
26701889 |
TMEFF2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
34339705 |
CCNE1 |
DNA |
upregulated |
treatment |
targeted therapy |
tissue |
26647729 |
CD44 |
protein |
upregulated |
prognosis |
favorable |
tissue |
26608413 |
CD133 |
protein |
upregulated |
prognosis |
favorable |
tissue |
26608413 |
TOP2A |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26588239 |
TOP2A |
protein |
upregulated |
treatment |
receiving adjuvant taxane-platinum regimens |
tissue |
26588239 |
CDK4 |
protein |
upregulated |
prognosis |
recurrence |
tissue |
26554657 |
CDK6 |
protein |
upregulated |
treatment |
chemosensitive |
tissue |
26554657 |
CDK4 |
protein |
upregulated |
prognosis |
recurrence |
tissue |
26554657 |
CDK6 |
protein |
upregulated |
treatment |
chemosensitive |
tissue |
26554657 |
HE4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26539494 |
SMOC-2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
34339705 |
ANXA2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26362938 |
HE4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26362938 |
ANXA2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26362938 |
SPAG9 |
protein |
upregulated |
treatment |
progestin treatment |
tissue |
26334303 |
SPAG9 |
protein |
upregulated |
treatment |
progestin treatment |
tissue |
26334303 |
SPAG9 |
protein |
upregulated |
prognosis |
progestin treatment |
tissue |
26334303 |
SPAG9 |
protein |
upregulated |
prognosis |
progestin treatment |
tissue |
26334303 |
ATAD2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26308378 |
ATAD2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
26308378 |
PGI |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26308071 |
SOX17 |
protein |
upregulated |
prognosis |
favorable |
tissue |
34339705 |
HE4 |
protein |
upregulated |
diagnosis |
|
tissue |
26265413 |
CDC20 |
protein |
upregulated |
prognosis |
unfavorable(dvanced tumor stage ) |
tissue |
26245990 |
CDC20 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26245990 |
COX-2 |
protein |
upregulated |
prognosis |
does not seem to be associated with prognostic factors or survival. |
tissue |
26222488 |
AMF |
protein |
upregulated |
prognosis |
unfavorable(AMF mediating EMT) |
tissue |
26201353 |
AMF |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26201353 |
Musashi-1 protein |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26191146 |
LSD1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
26166558 |
CDKN2A |
DNA |
differentially expressed |
diagnosis |
MT-EC(containing endometrioid and serous differentiation) |
tissue |
26132201 |
H19 |
DNA |
differentially expressed |
diagnosis |
MT-EC(containing endometrioid and serous differentiation) |
tissue |
26132201 |
microRNA-21 |
RNA |
upregulated |
prognosis |
unfavorable |
tissue |
34331128 |
HOMER2 |
DNA |
differentially expressed |
diagnosis |
MT-EC(containing endometrioid and serous differentiation) |
tissue |
26132201 |
TNNT1 |
DNA |
differentially expressed |
diagnosis |
MT-EC(containing endometrioid and serous differentiation) |
tissue |
26132201 |
TILs |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
26111272 |
LVSI |
Image |
upregulated |
diagnosis |
advanced stage uterine papillary tumor |
tissue |
26028082 |
Enolase-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
25951350 |
Enolase-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25951350 |
ANCCA |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25934333 |
Sam68 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25874492 |
ASRGL1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25858696 |
G9a |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
25613390 |
GABPA |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
34306255 |
Cyclin D1 |
protein |
upregulated |
diagnosis |
endometrial carcinogenesis and tumor cell proliferation |
tissue |
25511212 |
Ki67 |
protein |
upregulated |
diagnosis |
endometrial carcinogenesis and tumor cell proliferation |
tissue |
25511212 |
HAND2 |
protein |
downgulated |
diagnosis |
identification of atypical hyperplasia and Type I endometrial carcinoma |
tissue |
25473755 |
HAND2 |
protein |
downgulated |
diagnosis |
|
tissue |
25473755 |
HABP1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25355598 |
SATB1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25347096 |
cyclin B |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25315186 |
MSH2 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25310854 |
MLH1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25310854 |
MSH6 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25310854 |
GABPA |
protein |
downgulated |
treatment |
therapeutic target |
tissue |
34306255 |
PMS2 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25310854 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
IMP2 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
IMP2 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
cyclin E1 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
cyclin E1 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
HMGA2 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
TET1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
34731191 |
ARID1A |
protein |
downgulated |
prognosis |
favorable |
tissue |
34257552 |
HMGA2 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
FolR1 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
FolR1 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
PTEN |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
PTEN |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
estrogen receptor |
protein |
downgulated |
diagnosis |
|
tissue |
25282036 |
estrogen receptor |
protein |
downgulated |
diagnosis |
|
tissue |
25282036 |
estrogen receptor |
protein |
downgulated |
diagnosis |
|
tissue |
25282036 |
ARID1A |
protein |
downgulated |
prognosis |
favorable |
tissue |
34257552 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
25282036 |
Intraepithelial CD3(+) TIL counts |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25275055 |
CRHR1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
25254562 |
ANXA2 |
protein |
upregulated |
prognosis |
recurrent |
tissue |
25219463 |
ANXA2 |
protein |
upregulated |
prognosis |
recurrent |
tissue |
25219463 |
WT-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25033726 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
25022554 |
Yes-associated protein (YAP) |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24972085 |
Yes-associated protein (YAP) |
protein |
upregulated |
treatment |
therapeutic target/predict radiation sensitivity |
tissue |
24972085 |
Rictor |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
24966915 |
isoform B of progesterone receptor |
protein |
downgulated |
prognosis |
predicted faster remission |
tissue |
34162378 |
Rictor |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24966915 |
CYP1A1 |
protein |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
CYP1A1 |
DNA |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
CYP1B1 |
protein |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
CYP1B1 |
DNA |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
KPNA2 |
protein |
upregulated |
diagnosis |
identification of patients who need more aggressive treatment regimens. |
tissue |
24930886 |
MRE11 |
protein |
downgulated |
treatment |
sensitivity to PARP-inhibitor |
tissue |
24927325 |
HSF1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24853175 |
FOXA1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
24849812 |
FOXA1 |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
24849812 |
lncRNA NEAT1 |
RNA |
upregulated |
treatment |
therapeutic targe |
tissue |
34153644 |
POLE |
DNA |
exonuclease domain mutations |
prognosis |
favorable |
tissue |
24844595 |
ER |
protein |
ER+PR+P53-PTEN+ |
prognosis |
favorable |
tissue |
24762589 |
PR |
protein |
ER+PR+P53-PTEN+ |
prognosis |
favorable |
tissue |
24762589 |
P53 |
protein |
ER+PR+P53-PTEN+ |
prognosis |
favorable |
tissue |
24762589 |
PTEN |
protein |
ER+PR+P53-PTEN+ |
prognosis |
favorable |
tissue |
24762589 |
ER |
protein |
ER-PR-P53+PTEN- |
prognosis |
unfavorable |
tissue |
24762589 |
PR |
protein |
ER-PR-P53+PTEN- |
prognosis |
unfavorable |
tissue |
24762589 |
P53 |
protein |
ER-PR-P53+PTEN- |
prognosis |
unfavorable |
tissue |
24762589 |
PTEN |
protein |
ER-PR-P53+PTEN- |
prognosis |
unfavorable |
tissue |
24762589 |
S100A4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24756855 |
ALDH1 |
protein |
upregulated |
prognosis |
progression of premalignan |
tissue |
34099751 |
S100A4 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
24756855 |
HDGF |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24692842 |
CGRRF1 |
DNA |
downgulated |
treatment |
metformin respons |
tissue |
24680596 |
MMP2 |
protein |
upregulated |
diagnosis |
malignant biomarker |
tissue |
24670463 |
DJ-1 |
protein |
|
diagnosis |
types I and II |
tissue |
24614826 |
DJ-1 |
protein |
|
diagnosis |
|
tissue |
24614826 |
TNFAIP8 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24590269 |
stathmin |
protein |
upregulated |
treatment |
paclitaxel treatment |
tissue |
24587245 |
miR-203 |
RNA |
hypermethylation |
diagnosis |
endometrioid and clear endometrial sub-cancers. |
tissue |
24530564 |
miR-203 |
RNA |
hypermethylation |
diagnosis |
endometrioid and clear endometrial sub-cancers. |
tissue |
24530564 |
microRNA 21 |
RNA |
upregulated |
diagnosis |
malignant biomarker |
tissue |
34086554 |
RASSF1 |
DNA |
upregulate methylation |
prognosis |
unfavorable |
tissue |
24464006 |
RASSF1 |
DNA |
methylation |
prognosis |
prognostic factor of endometrial carcinogenesis |
tissue |
24464006 |
CDH1 |
DNA |
upregulated |
diagnosis |
progression and metastases |
tissue |
24455846 |
ITGB1 |
DNA |
upregulated |
diagnosis |
progression and metastases |
tissue |
24455846 |
GdA |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24377825 |
maspin |
protein |
upregulated |
diagnosis |
endometrial hyperplasia and endometrial adenocarcinoma |
tissue |
24346847 |
estrogen receptor-α |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24335662 |
CD117 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
24333732 |
CD117 |
protein |
upregulated |
treatment |
therapeutic target(targeting of the SCF/CD117 axis) |
tissue |
24333732 |
RAGE |
protein |
upregulated |
diagnosis |
immune modulatory factor |
tissue |
33922995 |
URI |
protein |
upregulated |
diagnosis |
|
tissue |
24228101 |
URI |
protein |
upregulated |
prognosis |
high-grade endometrioid adenocarcinomas |
tissue |
24228101 |
E-Cadherin |
protein |
upregulated |
prognosis |
favorable |
tissue |
24222154 |
MAI |
protein |
upregulated |
prognosis |
predict recurrence |
tissue |
24146786 |
PPH3 |
protein |
upregulated |
prognosis |
predict recurrence |
tissue |
24146786 |
Ki-67 |
protein |
upregulated |
prognosis |
predict recurrence |
tissue |
24146786 |
napsin A |
protein |
upregulated |
diagnosis |
clear cell histotype |
tissue |
24145649 |
Pin1 |
protein |
upregulated |
prognosis |
prognostic marker as PR in patients with endometrial cancer |
tissue |
24067230 |
CyclinD1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23947899 |
ER |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23932335 |
IDO1 |
protein |
upregulated |
diagnosis |
immune modulatory factor |
tissue |
33922995 |
PR |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23932335 |
ER |
protein |
downgulated |
prognosis |
predict lymph node metastasis |
tissue |
23932335 |
PR |
protein |
downgulated |
prognosis |
predict lymph node metastasis |
tissue |
23932335 |
Ki-67 |
protein |
downgulated |
prognosis |
favorable, select patients
with ESS for fertility-preservation surgery |
tissue |
23896713 |
ER |
protein |
upregulated |
prognosis |
favorable, select patients
with ESS for fertility-preservation surgery |
tissue |
23896713 |
PR |
protein |
upregulated |
prognosis |
favorable, select patients
with ESS for fertility-preservation surgery |
tissue |
23896713 |
hPEBP4 |
protein |
upregulated |
treatment |
potential target |
tissue |
23818363 |
OATP1B3 |
protein |
upregulated |
prognosis |
favorable, treated with adjuvant TC chemotherapy. |
tissue |
23782748 |
CTR1 |
protein |
upregulated |
prognosis |
favorable treated with adjuvant TC chemotherapy. |
tissue |
23782748 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable, predicting recurrence |
tissue |
23781004 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33858677 |
progesterone receptor |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23777659 |
ProExC |
protein |
upregulated |
diagnosis |
differentiating ECA from EMA |
tissue |
23719407 |
C2GnT1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23617619 |
PTEN |
protein |
upregulated |
diagnosis |
|
tissue |
23613406 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
23613406 |
PTEN |
protein |
upregulated |
prognosis |
favorable treated with adjuvant TC chemotherapy. |
tissue |
23613406 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23613406 |
S38 |
protein |
upregulated |
diagnosis |
|
tissue |
23538402 |
P53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23524907 |
Visfatin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23438672 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33858677 |
hypoxia-inducible factor 1α |
protein |
upregulated |
diagnosis |
aggressive phenotype |
tissue |
23372184 |
TWIST |
protein |
upregulated |
diagnosis |
aggressive phenotype |
tissue |
23372184 |
E-cadherin |
protein |
upregulated |
diagnosis |
aggressive phenotype |
tissue |
23372184 |
Bub1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23334889 |
Mad2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23334889 |
Bub1 |
protein |
downgulated |
diagnosis |
EECs and NEECs |
tissue |
23334889 |
Mad2 |
protein |
upregulated |
diagnosis |
EECs and NEECs |
tissue |
23334889 |
Wnt7a |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23321718 |
ERα |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23266443 |
ERβ1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23266443 |
TET1 |
protein |
downgulated |
diagnosis |
|
tissue |
34731191 |
ER |
protein |
p53/L1CAM/ER/PR expression,for ER/PR- |
prognosis |
unfavorable |
tissue |
33858677 |
ERα |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23266443 |
ERβ1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
23266443 |
ER-α36 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23257935 |
ER-α36 |
protein |
upregulated |
treatment |
|
tissue |
23257935 |
ER-α36 |
protein |
upregulated |
diagnosis |
|
tissue |
23257935 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23221606 |
ki67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23221606 |
GRP78 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
23200913 |
E-cadherin |
protein |
EMT |
prognosis |
unfavorable |
tissue |
23114646 |
Snail |
protein |
EMT |
prognosis |
unfavorable |
tissue |
23114646 |
PR |
protein |
p53/L1CAM/ER/PR expression,for ER/PR- |
prognosis |
unfavorable |
tissue |
33858677 |
ERRγ |
protein |
ERRγ-positive/ERα-negative status |
prognosis |
unfavorable |
tissue |
23051957 |
ERα |
protein |
ERRγ-positive/ERα-negative status |
prognosis |
unfavorable |
tissue |
23051957 |
ERRγ |
protein |
ERRγ-positive/ERα-negative status |
treatment |
|
tissue |
23051957 |
ERα |
protein |
ERRγ-positive/ERα-negative status |
treatment |
|
tissue |
23051957 |
cyclin D1 |
protein |
upregulated |
diagnosis |
indicator of YWHAE-FAM22 ESS |
tissue |
22982899 |
PKM2 |
protein |
upregulated |
diagnosis |
predict high-risk endometrial carcinoma |
tissue |
22889453 |
HSPA5 |
protein |
upregulated |
diagnosis |
predict high-risk endometrial carcinoma |
tissue |
22889453 |
PKM2 |
protein |
upregulated |
diagnosis |
predict high-risk endometrial carcinoma |
tissue |
22889453 |
HSPA5 |
protein |
upregulated |
diagnosis |
predict high-risk endometrial carcinoma |
tissue |
22889453 |
MMSET |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22886632 |
mesothelin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33832498 |
DNA ploidy |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22824999 |
DNA ploidy |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22824999 |
fascin |
protein |
upregulated |
prognosis |
different steps of extracellular matrix invasion |
tissue |
22784357 |
CD44v6 |
protein |
upregulated |
prognosis |
not prognosis |
tissue |
22784357 |
BST2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
22729361 |
IPO13 |
protein |
upregulated |
diagnosis |
|
tissue |
22648251 |
pHH3 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22644303 |
survivin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22644303 |
emmprin |
protein |
downgulated |
prognosis |
favorable |
tissue |
22640183 |
emmprin |
protein |
downgulated |
treatment |
theranostic target |
tissue |
22640183 |
mesothelin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33832498 |
bFGF |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22617129 |
miR-125b |
RNA |
aberrantly expressed |
treatment |
targeting ERBB2 |
tissue |
22460089 |
podocalyxin |
protein |
upregulated |
diagnosis |
aggressive phenotype |
tissue |
22412054 |
pEzrin |
protein |
upregulated |
diagnosis |
aggressive phenotype |
tissue |
22412054 |
TIMP-2 |
protein |
upregulated |
prognosis |
favorable |
tissue |
22270451 |
HMGA2 |
protein |
upregulated |
diagnosis |
|
tissue |
22250726 |
phosphatidylinositol 3'-kinase pathway alteration |
protein |
pathway alteration |
prognosis |
favorable |
tissue |
22209294 |
SPAG9 |
protein |
upregulated |
diagnosis |
early detection of endometrial carcinoma. |
tissue |
22146769 |
endoglin |
DNA |
upregulated |
prognosis |
not significantly altered |
tissue |
22116456 |
endoglin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
22116456 |
CA125 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33832498 |
MMP-2 |
protein |
upregulated |
diagnosis |
different stages of endometriosis and in endometrial cancer |
tissue |
22056701 |
MMP-9 |
protein |
upregulated |
diagnosis |
different stages of endometriosis and in endometrial cancer |
tissue |
22056701 |
PCNA |
protein |
upregulated |
diagnosis |
different stages of endometriosis and in endometrial cancer |
tissue |
22056701 |
CA-125 |
protein |
upregulated |
diagnosis |
|
tissue |
22037740 |
CA-125 |
protein |
upregulated |
diagnosis |
|
tissue |
22037740 |
p16 |
protein |
upregulated |
diagnosis |
|
tissue |
22027748 |
CXCL12 |
protein |
upregulated |
prognosis |
favorable |
tissue |
22025313 |
SNCG |
protein |
upregulated |
diagnosis |
aggressive tumor behavior and adverse outcome |
tissue |
22015044 |
survivin |
DNA |
allele C |
treatment |
therapeutic implications |
tissue |
21897272 |
hPRL |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21849525 |
Plasma-derived exosomal miR-15a-5p |
RNA |
upregulated |
diagnosis |
|
tissue |
33781255 |
hGH |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21849525 |
Beclin 1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21741077 |
GDF-15 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21616994 |
p21 |
DNA |
low p21(<1%) , high survivin expression(>158) and high microsatellite instability |
prognosis |
unfavorable |
tissue |
21552210 |
survivin |
DNA |
low p21(<1%) , high survivin expression(>158) and high microsatellite instability |
prognosis |
unfavorable |
tissue |
21552210 |
Microsatellite instability |
DNA |
low p21(<1%) , high survivin expression(>158) and high microsatellite instability |
prognosis |
unfavorable |
tissue |
21552210 |
epithelial cell size ratio |
Image |
higher epithelial cell size ratio after 4 weeks + lower Ki-67 nuclear antigen labeling |
treatment |
progestin therapy |
tissue |
21551965 |
Ki-67 nuclear antigen labeling |
protein |
higher epithelial cell size ratio after 4 weeks + lower Ki-67 nuclear antigen labeling |
treatment |
progestin therapy |
tissue |
21551965 |
CD151 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21505452 |
HE4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21468050 |
CHK1 |
protein |
upregulated |
prognosis |
favorable |
tissue |
33754208 |
microRNA-145 |
RNA |
upregulated |
diagnosis |
grading endometrial carcinoma |
tissue |
21365617 |
Stathmin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21242118 |
Stathmin |
protein |
upregulated |
treatment |
redict response to PI3Kinase inhibition |
tissue |
21242118 |
ALDH1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21231983 |
Nrf2 |
protein |
upregulated |
diagnosis |
|
tissue |
21228930 |
PTTG1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21181309 |
PTEN |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
21181309 |
inhibin-α subunit |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21174065 |
MVD |
Image |
upregulated |
prognosis |
unfavorable |
tissue |
21103625 |
VEGF |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
21103625 |
FBXW7 |
protein |
upregulated |
prognosis |
favorable |
tissue |
33754208 |
MSI-H status |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
21079294 |
E-cadherin |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
20874004 |
CDH1 |
DNA |
hypermethylation |
prognosis |
unfavorable |
tissue |
20874004 |
E-cadherin |
protein |
upregulated |
treatment |
theranostic target |
tissue |
20874004 |
CDH1 |
DNA |
hypermethylation |
treatment |
therapeutic targe |
tissue |
20874004 |
HAI-1 |
protein |
upregulated |
prognosis |
favorable |
tissue |
20715109 |
HAI-2 |
protein |
upregulated |
prognosis |
favorable |
tissue |
20715109 |
HAI-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
20715109 |
HAI-2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
20715109 |
YT521 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
20686370 |
PPP2R1B |
protein |
upregulated |
prognosis |
favorable |
tissue |
33754208 |
YT521 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
20686370 |
HIF-1alpha |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
20565904 |
Glut-1 |
protein |
upregulated |
diagnosis |
endometrial intraepithelial neoplasia |
tissue |
20527231 |
beta-catenin |
protein |
abnormal expression |
diagnosis |
endometrial intraepithelial neoplasia |
tissue |
20527231 |
L1CAM |
protein |
upregulated |
diagnosis |
identify endometrioid ECs that have type 2-like features |
tissue |
20077528 |
MSI |
DNA |
MSI |
prognosis |
unfavorable |
tissue |
20005452 |
myocardin |
protein |
upregulated |
diagnosis |
distinguishing uterine smooth muscle tumors from ESSs |
tissue |
19952936 |
myocardin |
protein |
upregulated |
diagnosis |
distinguishing uterine smooth muscle tumors from ESSs |
tissue |
19952936 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19855378 |
FAK |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19823058 |
Ki-67 |
protein |
upregulated |
prognosis |
recurrence |
tissue |
33714260 |
DNA ploidy |
DNA |
aneuploid |
prognosis |
unfavorable |
tissue |
19800606 |
Claudins |
protein |
upregulated |
diagnosis |
|
tissue |
19795358 |
Claudins |
protein |
upregulated |
prognosis |
|
tissue |
19795358 |
Claudins |
protein |
upregulated |
treatment |
|
tissue |
19795358 |
RFP |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19650860 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19509570 |
DKK1 |
protein |
upregulated |
diagnosis |
screening the progression |
tissue |
19424619 |
TIL |
cell |
upregulated |
prognosis |
favorable |
tissue |
19411095 |
intra-tumoralCD8(+) T-lymphocytes |
cell |
upregulated |
prognosis |
favorable |
tissue |
19411095 |
intra-tumoralCD8(+) |
cell |
upregulated |
prognosis |
favorable |
tissue |
19411095 |
TET1 |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
34731191 |
miR-375 |
RNA |
downgulated |
diagnosis |
distinguish the high grade best from the low grade EC |
tissue |
33668431 |
FoxP3(+) |
cell |
upregulated |
prognosis |
favorable |
tissue |
19411095 |
intra-tumoralCD45R0(+) lymphocytes |
cell |
upregulated |
prognosis |
favorable |
tissue |
19411095 |
EphA2 |
protein |
upregulated |
treatment |
hormone receptor-negative |
tissue |
19396818 |
osteopontin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19194826 |
Ki-67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19133508 |
ER |
protein |
ER-PR status |
prognosis |
unfavorable |
tissue |
19133508 |
PR |
protein |
ER-PR status |
prognosis |
unfavorable |
tissue |
19133508 |
Cathepsin-B |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
19110306 |
progesterone receptor (PR)-A |
protein |
downgulated |
prognosis |
favorable |
tissue |
19108875 |
ER-alpha |
protein |
downgulated |
prognosis |
favorable |
tissue |
19108875 |
miR-190b |
RNA |
downgulated |
diagnosis |
distinguish the high grade best from the low grade EC |
tissue |
33668431 |
SOD |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
18797802 |
TFF3 |
protein |
upregulated |
diagnosis |
|
tissue |
18682706 |
TFF3 |
DNA |
upregulated |
diagnosis |
|
tissue |
18682706 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
18565690 |
BMI-1 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
18475299 |
BMI-1 |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
18475299 |
ADAM19 |
protein |
upregulated |
prognosis |
the progress and prognosis of endometrial carcinoma |
tissue |
18458692 |
Midkine (MK) |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
18422745 |
NDRG1 |
protein |
upregulated |
diagnosis |
early detection of endometrial carcinoma. |
tissue |
18377423 |
PTEN |
protein |
downgulated |
diagnosis |
early detection of endometrial carcinoma. |
tissue |
18377423 |
BMP-10 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33635467 |
beta-catenin |
protein |
exon 3 |
diagnosis |
|
tissue |
18376386 |
beta-catenin |
DNA |
exon 3 |
diagnosis |
|
tissue |
18376386 |
Prostate-specific membrane antigen |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
18349274 |
Prostate-specific membrane antigen |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
18349274 |
aquaporin-1 (AQP1) |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
18313673 |
TAMs |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
18289648 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
18223334 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
18223334 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
18223334 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
18223334 |
SATB2 |
protein |
upregulated |
diagnosis |
Separating atypical endometrioid glands is more consistent with
APAM than with myoinvasive |
tissue |
33459390 |
IMP3 |
protein |
upregulated |
diagnosis |
endometrial stroma of gestational endometrium and chorionic villi |
tissue |
18223334 |
serum p53 antibody (S-p53 Ab) |
protein |
upregulated |
diagnosis |
|
tissue |
17980190 |
c-erb-B2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17890888 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
17885673 |
IMP3 |
protein |
upregulated |
diagnosis |
|
tissue |
17885673 |
p53 |
protein |
upregulated |
diagnosis |
|
tissue |
17885673 |
HLDF factor |
protein |
Antibodies to the HLDF factor |
diagnosis |
|
tissue |
17722590 |
FOLR1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17582475 |
Microsatellite instability |
DNA |
MSI-high |
prognosis |
unfavorable |
tissue |
17527071 |
BNIP3 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17513511 |
p16 |
protein |
upregulated |
diagnosis |
Separating atypical endometrioid glands is more consistent with
APAM than with myoinvasive |
tissue |
33459390 |
PTEN |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
17504383 |
beta-catenin |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
17504383 |
GPR30 |
protein |
upregulated |
prognosis |
unfavorable, high-risk endometrial cancer patients with lower survival rates. |
tissue |
17403429 |
CD24 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17139987 |
oestrogen receptor |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
17130035 |
Ki-67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17130035 |
Indoleamine 2,3-dioxygenase |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17117179 |
ephrinB2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
17108150 |
EphB4 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
17108150 |
ephrinB2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17108150 |
MMR protein |
protein |
methylation status |
treatment |
response to adjuvant therapy |
tissue |
33449452 |
EphB4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17108150 |
HIF-1alpha |
protein |
upregulated |
diagnosis |
aggressive potentia in type I |
tissue |
17099695 |
ERalpha |
protein |
upregulated |
prognosis |
favorable |
tissue |
17068614 |
ERRalpha |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17068614 |
ERalpha |
protein |
upregulated |
prognosis |
|
tissue |
17068614 |
ERRalpha |
protein |
upregulated |
prognosis |
|
tissue |
17068614 |
versican |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
17065588 |
PRB |
DNA |
downgulated |
prognosis |
risk factor in disease-free survival of the patients |
tissue |
16999816 |
PRA |
protein |
downgulated |
prognosis |
risk factor in disease-free survival of the patients |
tissue |
16999816 |
PRA |
DNA |
downgulated |
prognosis |
risk factor in disease-free survival of the patients |
tissue |
16999816 |
peritumoral Lymphocytes' Band-like Structure |
Image |
upregulated |
prognosis |
unfavorable |
tissue |
33419819 |
PRB |
protein |
downgulated |
prognosis |
risk factor in disease-free survival of the patients |
tissue |
16999816 |
AIB1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16980945 |
Nm23 |
protein |
upregulated |
prognosis |
favorable |
tissue |
16919631 |
GLUT1 |
protein |
upregulated |
diagnosis |
|
tissue |
16892013 |
GLUT8 |
protein |
upregulated |
diagnosis |
|
tissue |
16892013 |
KLK8 |
protein |
upregulated |
diagnosis |
|
tissue |
16888409 |
TADG-14 |
DNA |
upregulated |
diagnosis |
|
tissue |
16888409 |
KLK8 |
DNA |
upregulated |
diagnosis |
|
tissue |
16888409 |
CD105 |
protein |
upregulated |
prognosis |
favorable |
tissue |
16854456 |
LDH-5 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16837029 |
estrogen receptor |
protein |
upregulated |
prognosis |
|
tissue |
33338506 |
Lactoferrin (Lf) |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16820900 |
E-cadherin |
protein |
upregulated |
prognosis |
favorable |
tissue |
16803534 |
alpha-catenin |
protein |
upregulated |
prognosis |
favorable |
tissue |
16803534 |
beta-catenin |
protein |
upregulated |
prognosis |
favorable |
tissue |
16803534 |
HER-2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16710036 |
HER-2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16710036 |
ERRalpha |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
16681769 |
ERRgamma |
DNA |
upregulated |
prognosis |
favorable |
tissue |
16681769 |
CRBP-1 |
protein |
downgulated |
diagnosis |
additional useful tool for grading of endometrial carcinoma and may help to detect areas of differentiation |
tissue |
16575402 |
CRBP-1 |
protein |
downgulated |
treatment |
potential target for pharmacological strategies aimed to counteract its progression by increased intracellular retinol bioavailability. |
tissue |
16575402 |
progesterone receptor |
protein |
upregulated |
prognosis |
|
tissue |
33338506 |
Twist |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16564917 |
Twist |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
16564917 |
HDAC8 |
protein |
upregulated |
diagnosis |
smooth muscle differentiation |
tissue |
16538051 |
p27 |
protein |
upregulated |
treatment |
predicting marker for medroxyprogesterone acetate therapy |
tissue |
16515645 |
Haymaker |
DNA |
upregulated |
diagnosis |
|
tissue |
16495475 |
cyclin H |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16445666 |
cyclin H |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16445666 |
EIG121 |
DNA |
upregulated |
prognosis |
hyperestrogenic state and estrogen-related |
tissue |
16322283 |
Aurora B |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16311121 |
14-3-3sigma |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
16243811 |
folate receptor alpha |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
33323854 |
skp2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16080017 |
S100 |
protein |
upregulated |
prognosis |
favorable |
tissue |
16033094 |
dendritic cells |
CEll |
upregulated |
prognosis |
favorable |
tissue |
16033094 |
dendritic cells infiltration |
CEll |
DC-rich |
prognosis |
favorable |
tissue |
16033094 |
beta-catenin (CTNNB1) |
protein |
mutations |
prognosis |
favorable |
tissue |
16021566 |
c-FLIP |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
16014121 |
PTEN |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
15948123 |
morphometric D score |
OTHERS |
downgulated |
prognosis |
unfavorable |
tissue |
15948123 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
15938828 |
SMA |
protein |
upregulated |
diagnosis |
|
tissue |
15938828 |
TET1 |
DNA |
downgulated |
diagnosis |
|
tissue |
34731191 |
P53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33237570 |
HER-2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15938112 |
Ki-67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15938112 |
ATP7B |
protein |
upregulated |
prognosis |
unfavorable,in patients treated with cisplatin-based chemotherapy |
tissue |
15790435 |
DNA ploidy |
DNA |
|
prognosis |
|
tissue |
15755004 |
PR |
DNA |
downgulated |
prognosis |
risk of recurrence |
tissue |
15726651 |
MCM7 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15720416 |
c-erbB2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15678850 |
Smad7 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
15661223 |
Smad7 |
DNA |
upregulated |
treatment |
potential target to restore TGF-beta responsiveness |
tissue |
15661223 |
cytokeratin |
protein |
upregulated |
diagnosis |
predict lymph node micrometastasis |
tissue |
15498190 |
P53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33237570 |
cytokeratin |
protein |
upregulated |
diagnosis |
predict lymph node micrometastasis |
tissue |
15498190 |
CA125 |
protein |
upregulated |
diagnosis |
predict lymph node micrometastasis |
tissue |
15498190 |
CA125 |
protein |
upregulated |
diagnosis |
predict lymph node micrometastasis |
tissue |
15498190 |
P53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15363194 |
C-erbB-2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15363194 |
E-cadherin |
protein |
downgulated |
prognosis |
favorable |
tissue |
15328195 |
chaperonin 10 |
protein |
upregulated |
diagnosis |
|
tissue |
15253447 |
Intratumoral CD8+ T lymphocytes |
cell |
upregulated |
prognosis |
favorable |
tissue |
15240536 |
CD171 |
protein |
upregulated |
diagnosis |
detected subclinical
disease reconfirmed by the second-look surgery |
tissue |
15225093 |
placental leucine aminopeptidase |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15218296 |
P53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33237570 |
vascular invasion |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15139995 |
tumour cell proliferation (Ki67) |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15139995 |
p53 index |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15084841 |
DNA ploidy |
DNA |
DNA ploidy |
prognosis |
unfavorable |
tissue |
15068320 |
P-cadherin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15051772 |
p53 |
protein |
upregulated |
diagnosis |
predicting aggressive behavior |
tissue |
15032075 |
cFLIP |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
15025952 |
telomerase |
protein |
high telomerase activity and short telomere lengths |
prognosis |
unfavorable |
tissue |
15025282 |
DNA ploidy |
DNA |
diploid versus nondiploid; RR 5.1 |
prognosis |
|
tissue |
14981988 |
uPA |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
14976916 |
TWIST1 |
protein |
upregulated |
diagnosis |
diagnosis AHs and type I ECs. |
tissue |
33235117 |
c-myc |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
14764041 |
fatty acid synthase (FAS) |
protein |
upregulated |
prognosis |
increased risk of recurrence |
tissue |
14751145 |
angiodensity |
Image |
upregulated |
prognosis |
unfavorable |
tissue |
14674140 |
CD105 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
14629267 |
oxytocin receptor |
protein |
upregulated |
diagnosis |
distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma |
tissue |
14576480 |
PTEN |
DNA |
downgulated |
diagnosis |
|
tissue |
12948417 |
PTEN |
protein |
downgulated |
diagnosis |
earliest endometrial precancers and adenocarcinoma. |
tissue |
12948417 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12895227 |
MIB1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12893199 |
HER-2 |
protein |
HER-2:CEP17 ratio > 4 < or = 5 |
prognosis |
unfavorable |
tissue |
12866577 |
LGALS3BP |
protein |
upregulated |
diagnosis |
|
tissue |
33208911 |
CEP17 |
DNA |
HER-2:CEP17 ratio > 4 < or = 5 |
prognosis |
unfavorable |
tissue |
12866577 |
IGF-IR |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12866376 |
CA-125 |
protein |
upregulated |
prognosis |
marker of malignant cell transformation |
tissue |
12820350 |
endoglin (CD105) |
protein |
upregulated |
prognosis |
positive correlation with angiolymphatic invasion, lymph node metastases, and tumor stage. |
tissue |
12819391 |
Elf-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12798703 |
cyclin A |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12792921 |
17beta-HSD type 2 |
protein |
in situ abundance |
treatment |
progestogen treatment |
tissue |
12780745 |
PRB |
protein |
in situ abundance |
treatment |
progestogen treatment |
tissue |
12780745 |
CD44 variant 6 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12747468 |
Microvessel density index |
Image |
|
prognosis |
unfavorable |
tissue |
12722380 |
LGALS3BP |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
33208911 |
beta-catenin |
protein |
|
treatment |
progestogen treatment |
tissue |
12708483 |
KAI1 |
DNA |
down-regulated |
prognosis |
unfavorable |
tissue |
12684410 |
Ki-S1 |
protein |
upregulated |
diagnosis |
classifying patients into subgroups with low and high risk of relapseA |
tissue |
12556100 |
CaMKIV |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12525874 |
h-caldesmon |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
h-caldesmon |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
calponin |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
calponin |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
PPARγ(-) |
protein |
PPARγ(-)/ERRα (+)ratio≤1.86 |
prognosis |
unfavorable |
tissue |
33197888 |
Desmin |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
Desmin |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
SMA |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
SMA |
protein |
upregulated |
diagnosis |
|
tissue |
12485478 |
UPAR |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12130664 |
Ribosomal DNA methylation |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
12115383 |
Cyclin A |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
12073048 |
AgNORs |
protein |
upregulated |
treatment |
predict, as early as after the first fraction, the
local control of disease by a full radiotherapy protocol. |
tissue |
11917578 |
MUC1 |
protein |
downgulated |
prognosis |
favorable |
tissue |
11903603 |
MUC1 |
protein |
downgulated |
prognosis |
favorable |
tissue |
11903603 |
ERRα |
protein |
PPARγ(-)/ERRα (+)ratio≤1.86 |
prognosis |
unfavorable |
tissue |
33197888 |
VEGF |
protein |
upregulated |
prognosis |
favorable |
tissue |
11745191 |
KDR |
protein |
upregulated |
prognosis |
favorable |
tissue |
11745191 |
standard microvessel density (sMVD) |
Image |
upregulated |
prognosis |
unfavorable |
tissue |
11745191 |
VEGF |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
11745191 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
11532038 |
EMA |
protein |
upregulated |
prognosis |
recurrence |
tissue |
11520144 |
Nuclear p53 |
protein |
upregulated |
prognosis |
recurrence |
tissue |
11516808 |
telomerase |
protein |
upregulated |
prognosis |
recurrence |
tissue |
11431715 |
Id1 |
protein |
upregulated |
diagnosis |
malignant potential |
tissue |
11275368 |
VEGF |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
11161861 |
HE4 |
protein |
upregulated |
diagnosis |
predicte advanced disease |
tissue |
33156532 |
cytokeratin |
protein |
upregulated |
prognosis |
risk factor of recurrence |
tissue |
11161851 |
PAI-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
11136569 |
telomerase activity |
protein |
upregulated |
diagnosis |
|
tissue |
11078809 |
TERT |
DNA |
upregulated |
diagnosis |
|
tissue |
11078809 |
telomerase |
protein |
upregulated |
prognosis |
progression |
tissue |
10920935 |
metallothioneins |
protein |
upregulated |
diagnosis |
aggressive behaviour |
tissue |
10878548 |
PTEN |
DNA |
Altered expression |
diagnosis |
earliest endometrial precancers |
tissue |
10841828 |
PTEN |
protein |
Altered expression |
diagnosis |
earliest endometrial precancers |
tissue |
10841828 |
Flt-4 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10831352 |
CK-20 |
RNA |
upregulated |
diagnosis |
cells-micrometastases in lymph node (LN) |
tissue |
10831349 |
FTO |
DNA |
upregulated |
treatment |
therapeutic target |
tissue |
33103587 |
p16INK4aa |
DNA |
downgulated |
prognosis |
unfavorable |
tissue |
10656444 |
p16INK4aa |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
10656444 |
p53 |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
10600396 |
MIB-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10600302 |
anti-repp 86 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10452508 |
KGFR |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10427121 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10376438 |
HER-2/neu |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
10202671 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
10202671 |
PR |
protein |
downgulated |
prognosis |
unfavorable;lymph node metastases |
tissue |
10053107 |
IFITM1 |
protein |
upregulated |
diagnosis |
|
tissue |
34556086 |
FTO |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
33103587 |
cathepsin D (Cat D) |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
10027332 |
Ki-S4 PA |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
9934583 |
PTEN |
DNA |
mutation |
prognosis |
favorable |
tissue |
9865913 |
syndecan-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9857223 |
Ki-67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9829742 |
CK-20 |
protein |
upregulated |
diagnosis |
|
tissue |
9790796 |
CK-20 |
DNA |
upregulated |
diagnosis |
|
tissue |
9790796 |
PR |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
9648591 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9646853 |
Langerhans cell |
cell |
upregulated |
prognosis |
favorable |
tissue |
9596268 |
mismatch repair status |
DNA |
mismatch repair deficiency |
treatment |
predictive biomarker for hormone therapy respons |
tissue |
33039397 |
vimentin |
cell |
upregulated |
prognosis |
favorable |
tissue |
9596268 |
GST-pi |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9570981 |
c-Jun |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9570981 |
p53 |
DNA |
abnormalities |
prognosis |
unfavorable |
tissue |
9422988 |
p21 |
DNA |
upregulated |
prognosis |
favorable |
tissue |
9422988 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
9422988 |
p21 |
protein |
upregulated |
prognosis |
favorable |
tissue |
9422988 |
cyclin A |
protein |
upregulated |
diagnosis |
high-grade endometrial endometrioid carcinomas |
tissue |
9421074 |
p53 |
protein |
upregulated |
diagnosis |
high-grade endometrial endometrioid carcinomas |
tissue |
9421074 |
growth fraction |
DNA |
upregulated |
prognosis |
|
tissue |
9340973 |
MHC class I status |
protein |
downgulated |
treatment |
resistance mechanism to immune checkpoint inhibition |
tissue |
33011747 |
DNA aneuploidy |
DNA |
DNA aneuploidy |
diagnosis |
biological markers for assessing progression to endometrial carcinoma. |
tissue |
9167896 |
SPF |
DNA |
upregulated |
diagnosis |
assessing progression to endometrial carcinoma |
tissue |
9167896 |
c-erbB-2 |
protein |
upregulated |
diagnosis |
assessing progression to endometrial carcinoma |
tissue |
9167896 |
CA 72-4 |
protein |
upregulated |
prognosis |
predicting and monitoring recurrence,extracorporeal spread |
tissue |
9038731 |
PCNA |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8936111 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8936111 |
c-erbB-2 protein |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8936111 |
S-phase fraction (SPF) |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
8909315 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8761370 |
desmoplakin I |
protein |
upregulated |
diagnosis |
their relation to cellular differentiation |
tissue |
8697392 |
MHC class I status |
protein |
downgulated |
treatment |
selecting endometrial cancer patients for checkpoint inhibition |
tissue |
33011747 |
desmoplakin II |
protein |
upregulated |
diagnosis |
their relation to cellular differentiation |
tissue |
8697392 |
desmoglein |
protein |
upregulated |
diagnosis |
their relation to cellular differentiation |
tissue |
8697392 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8695259 |
cathepsin D |
protein |
upregulated |
diagnosis |
their relation to cellular differentiation |
tissue |
8664123 |
MIB-1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8641618 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8610771 |
apoptotic index |
DNA |
|
prognosis |
unfavorable |
tissue |
8575739 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
8556702 |
AgNOR |
DNA |
upregulated |
diagnosis |
|
tissue |
8112955 |
EGFR |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
7909788 |
ER |
protein |
[ER + PR]/[P53 + Ki67]<0.92 |
prognosis |
recurrence |
tissue |
32920817 |
DNA ploidy |
DNA |
|
prognosis |
unfavorable |
tissue |
7909491 |
cathepsin D |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
7740849 |
PP-4 |
protein |
|
diagnosis |
|
tissue |
1833844 |
Plasminogen activator inhibitor-type 2 (PAI-2) |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
1427403 |
HER-2/neu |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
1361478 |
BANCR |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
27898420 |
CCAT1 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
32173521 |
tumor budding (TB) |
Image |
high-grade |
prognosis |
unfavorable |
tissue |
22198340 |
DJ-1 |
protein |
upregulated |
diagnosis |
|
tissue |
24614826 |
chondoadherin-like |
protein |
upregulated |
diagnosis |
|
tissue |
36052469 |
PR |
protein |
[ER + PR]/[P53 + Ki67]<0.92 |
prognosis |
recurrence |
tissue |
32920817 |
hsa_circ_0039569 |
RNA |
upregulated |
diagnosis |
N/A |
tissue |
31308756 |
circ_0001610 |
RNA |
upregulated |
diagnosis |
N/A |
tissue |
31308756 |
progesterone receptor |
protein |
upregulated |
prognosis |
N/A |
tissue |
33338506 |
circ_0001776 |
RNA |
downgulated |
diagnosis |
N/A |
tissue |
31308756 |
hsa_circ_0039569 |
RNA |
downgulated |
diagnosis |
N/A |
tissue |
31308756 |
hsa_circ_0000437 |
RNA |
downgulated |
diagnosis |
N/A |
tissue |
31308756 |
hsa_circ_0009043 |
RNA |
downgulated |
diagnosis |
N/A |
tissue |
31308756 |
citrullinated histone H3 |
protein |
upregulated |
diagnosis |
N/A |
tissue |
35449078 |
VEGFR2 |
protein |
upregulated |
treatment |
N/A |
tissue |
35241527 |
Claudin‑9 |
protein |
upregulated |
prognosis |
N/A |
tissue |
36129146 |
P53 |
protein |
[ER + PR]/[P53 + Ki67]<0.92 |
prognosis |
recurrence |
tissue |
32920817 |
PKN1 |
protein |
upregulated |
prognosis |
N/A |
tissue |
35533253 |
apolipoprotein E |
protein |
upregulated |
prognosis |
N/A |
tissue |
36123916 |
Suprabasin (SBSN) isoform 2 |
protein |
downgulated |
prognosis |
N/A |
tissue |
35216190 |
SLERT |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
36721236 |
KDM4B |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
35485290 |
YTHDF2 |
protein |
upregulated |
diagnosis |
EAH/EIN from EHWA |
tissues |
35512522 |
Tumor-associated Macrophages |
cell |
upregulated |
prognosis |
unfavorable |
tissues |
34282107 |
TP53 |
DNA |
mutations |
prognosis |
unfavorable |
tissues |
36251972 |
Pirh2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissues |
36251972 |
L1CAM |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
36251972 |
Ki67 |
protein |
[ER + PR]/[P53 + Ki67]<0.92 |
prognosis |
recurrence |
tissue |
32920817 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
36251972 |
Pirh2 |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
36251972 |
PDL-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35220229 |
SOX17 |
protein |
upregulated |
diagnosis |
N/A |
tissues |
36788073 |
Ki-67 |
protein |
upregulated |
diagnosis |
N/A |
tissues |
35891746 |
PD-L1 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
TIM-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
B7-H3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
Cyclin D1 |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
35156640 |
p53 |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
35156640 |
CDK9 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32901849 |
Ki-67 |
protein |
upregulated |
prognosis |
unfavorable |
tissues |
35156640 |
PRAME |
protein |
upregulated |
diagnosis |
N/A |
tissues |
35512215 |
V-domain Ig-containing suppressor of T-cell activation |
protein |
upregulated |
prognosis |
favorable |
tissues |
34493823 |
ARID1B |
protein |
upregulated |
diagnosis |
differentiation between DDEC/UDEC and NEC. |
tissues |
35394077 |
SMARCA4 |
protein |
upregulated |
diagnosis |
differentiation between DDEC/UDEC and NEC. |
tissues |
35394077 |
SMARCB1 |
protein |
upregulated |
diagnosis |
differentiation between DDEC/UDEC and NEC. |
tissues |
35394077 |
Zinc finger E-box binding homeobox 1 |
protein |
upregulated |
diagnosis |
N/A |
tissues |
35478361 |
sine oculis homeobox homolog 1 |
protein |
upregulated |
prognosis |
|
tissues |
35379118 |
lymphocyte activation gene-3 |
protein |
upregulated |
prognosis |
favorable |
tissues |
35749914 |
lymphocyte activation gene-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35749914 |
CDK9 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
32901849 |
EPM2AIP1 |
DNA |
upregulated |
diagnosis |
MLH1 promoter methylation |
tissue |
34772843 |
Tertiary lymphoid structures |
Image |
N/A |
prognosis |
|
tissue |
34689225 |
HER2 |
protein |
upregulated |
diagnosis |
|
tissue |
33782344 |
Ki67 |
protein |
upregulated |
diagnosis |
deep myometrial invasion |
tissue |
36918859 |
HER2 |
protein |
upregulated |
diagnosis |
|
tissue |
37094656 |
L1CAM |
protein |
upregulated |
treatment |
platinum response |
tissue |
35429348 |
L1CAM |
DNA |
upregulated |
treatment |
platinum response |
tissue |
35429348 |
KRT15 |
protein |
upregulated |
prognosis |
lymphovascular invasion, stromal cervical invasion |
tissue |
35866777 |
KRT15 |
DNA |
upregulated |
prognosis |
lymphovascular invasion, stromal cervical invasion |
tissue |
35866777 |
MMRd/MSI-H |
protein |
upregulated |
treatment |
response to immune checkpoint |
tissue |
34902958 |
CD10 |
protein |
upregulated |
diagnosis |
|
tissue |
34556086 |
nuclear beta-catenin |
protein |
|
NOT PROGONSIS |
|
tissue |
32897964 |
MutS homolog 2 |
DNA |
Increased MSH2 expression and reduced MSH2 methylation |
prognosis |
unfavorable |
tissue |
36208091 |
Ki67 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
36697084 |
E-cadherin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
36697084 |
р53+FOXP3-c-Myc+ |
protein |
р53+FOXP3-c-Myc+ |
diagnosis |
endometrioid carcinoma of the endometrium |
tissue |
36325701 |
HER2 |
protein |
upregulated |
treatment |
targeted therapy |
tissue |
36516643 |
vimentin |
protein |
downgulated |
prognosis |
unfavorable |
tissue |
35320951 |
ER |
protein |
upregulated |
prognosis |
|
tissue |
36690721 |
HER2 |
protein |
upregulated |
treatment |
targeted therapy |
tissue |
36939053 |
HER2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
35611517 |
HER2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
35611517 |
hsa_circ_0002577 |
RNA |
upregulated |
prognosis |
unfavorable |
tissue |
32847606 |
β-catenin |
protein |
upregulated |
diagnosis |
|
tissue |
36939046 |
Pax2 |
protein |
upregulated |
diagnosis |
|
tissue |
36939046 |
Pten |
protein |
upregulated |
diagnosis |
|
tissue |
36939046 |
ERα |
protein |
(ERα + PR)/(Ki67 + P53) |
diagnosis |
prediction of risk of lymph node metastasis in early-stage endometrial cancer |
tissue |
34456278 |
PR |
protein |
(ERα + PR)/(Ki67 + P53) |
diagnosis |
prediction of risk of lymph node metastasis in early-stage endometrial cancer |
tissue |
34456278 |
Ki67 |
protein |
(ERα + PR)/(Ki67 + P53) |
diagnosis |
prediction of risk of lymph node metastasis in early-stage endometrial cancer |
tissue |
34456278 |
P53 |
protein |
(ERα + PR)/(Ki67 + P53) |
diagnosis |
prediction of risk of lymph node metastasis in early-stage endometrial cancer |
tissue |
34456278 |
Lymphocyte activation gene (LAG)-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
36509464 |
tumor-reactive CD4+ TILs |
cell |
upregulated |
prognosis |
favorable |
tissue |
36581331 |
tumor-reactive CD8+ TILs |
cell |
upregulated |
prognosis |
favorable |
tissue |
36581331 |
hsa_circ_0002577 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
32847606 |
NHP2 |
gene |
downgulated |
prognosis |
favorable |
tissue |
35054812 |
VDAC1 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
32829673 |
VDAC2 |
DNA |
upregulated |
prognosis |
unfavorable |
tissue |
32829673 |
VDAC1 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32829673 |
VDAC2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32829673 |
TROP2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32769331 |
TROP2 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32769331 |
MSX1 |
protein |
upregulated |
prognosis |
favorable |
tissue |
32630554 |
SMA |
protein |
upregulated |
diagnosis |
|
tissue |
34556086 |
ARID1A |
protein |
downgulated |
treatment |
immune checkpoint inhibitor respons |
tissue |
32594230 |
mesothelin |
protein |
upregulated |
diagnosis |
risk group |
tissue |
32468249 |
mesothelin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32468249 |
mesothelin |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32468249 |
CA125 |
protein |
upregulated |
diagnosis |
risk group |
tissue |
32468249 |
CA125 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32468249 |
CA125 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32468249 |
KLF5 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32451988 |
KLF11 |
protein |
upregulated |
prognosis |
unfavorable |
tissue |
32451988 |
COX-2 |
protein |
upregulated |
diagnosis |
unfavorable |
tissue |
32433831 |